Form 8-K - Current report:
SEC Accession No. 0000950170-24-124546
Filing Date
2024-11-12
Accepted
2024-11-12 07:07:15
Documents
62
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20241112.htm   iXBRL 8-K 45446
2 EX-99.1 axsm-ex99_1.htm EX-99.1 234672
3 EX-99.2 axsm-ex99_2.htm EX-99.2 50328
4 GRAPHIC img36028404_0.jpg GRAPHIC 22496
5 GRAPHIC axsm-ex99_2s1.jpg GRAPHIC 363530
6 GRAPHIC axsm-ex99_2s2.jpg GRAPHIC 842989
7 GRAPHIC axsm-ex99_2s3.jpg GRAPHIC 436521
8 GRAPHIC axsm-ex99_2s4.jpg GRAPHIC 400429
9 GRAPHIC axsm-ex99_2s5.jpg GRAPHIC 237145
10 GRAPHIC axsm-ex99_2s6.jpg GRAPHIC 223041
11 GRAPHIC axsm-ex99_2s7.jpg GRAPHIC 328506
12 GRAPHIC axsm-ex99_2s8.jpg GRAPHIC 267540
13 GRAPHIC axsm-ex99_2s9.jpg GRAPHIC 354703
14 GRAPHIC axsm-ex99_2s10.jpg GRAPHIC 337742
15 GRAPHIC axsm-ex99_2s11.jpg GRAPHIC 279697
16 GRAPHIC axsm-ex99_2s12.jpg GRAPHIC 395878
17 GRAPHIC axsm-ex99_2s13.jpg GRAPHIC 207784
18 GRAPHIC axsm-ex99_2s14.jpg GRAPHIC 377184
19 GRAPHIC axsm-ex99_2s15.jpg GRAPHIC 228942
20 GRAPHIC axsm-ex99_2s16.jpg GRAPHIC 373186
21 GRAPHIC axsm-ex99_2s17.jpg GRAPHIC 254925
22 GRAPHIC axsm-ex99_2s18.jpg GRAPHIC 207663
23 GRAPHIC axsm-ex99_2s19.jpg GRAPHIC 378819
24 GRAPHIC axsm-ex99_2s20.jpg GRAPHIC 319613
25 GRAPHIC axsm-ex99_2s21.jpg GRAPHIC 338941
26 GRAPHIC axsm-ex99_2s22.jpg GRAPHIC 317473
27 GRAPHIC axsm-ex99_2s23.jpg GRAPHIC 273042
28 GRAPHIC axsm-ex99_2s24.jpg GRAPHIC 378359
29 GRAPHIC axsm-ex99_2s25.jpg GRAPHIC 280092
30 GRAPHIC axsm-ex99_2s26.jpg GRAPHIC 365980
31 GRAPHIC axsm-ex99_2s27.jpg GRAPHIC 320839
32 GRAPHIC axsm-ex99_2s28.jpg GRAPHIC 285784
33 GRAPHIC axsm-ex99_2s29.jpg GRAPHIC 352533
34 GRAPHIC axsm-ex99_2s30.jpg GRAPHIC 279810
35 GRAPHIC axsm-ex99_2s31.jpg GRAPHIC 381140
36 GRAPHIC axsm-ex99_2s32.jpg GRAPHIC 246714
37 GRAPHIC axsm-ex99_2s33.jpg GRAPHIC 322799
38 GRAPHIC axsm-ex99_2s34.jpg GRAPHIC 257378
39 GRAPHIC axsm-ex99_2s35.jpg GRAPHIC 373417
40 GRAPHIC axsm-ex99_2s36.jpg GRAPHIC 367293
41 GRAPHIC axsm-ex99_2s37.jpg GRAPHIC 304529
42 GRAPHIC axsm-ex99_2s38.jpg GRAPHIC 324016
43 GRAPHIC axsm-ex99_2s39.jpg GRAPHIC 281361
44 GRAPHIC axsm-ex99_2s40.jpg GRAPHIC 337664
45 GRAPHIC axsm-ex99_2s41.jpg GRAPHIC 344639
46 GRAPHIC axsm-ex99_2s42.jpg GRAPHIC 321588
47 GRAPHIC axsm-ex99_2s43.jpg GRAPHIC 342601
48 GRAPHIC axsm-ex99_2s44.jpg GRAPHIC 267694
49 GRAPHIC axsm-ex99_2s45.jpg GRAPHIC 370295
50 GRAPHIC axsm-ex99_2s46.jpg GRAPHIC 268203
51 GRAPHIC axsm-ex99_2s47.jpg GRAPHIC 326029
52 GRAPHIC axsm-ex99_2s48.jpg GRAPHIC 131239
  Complete submission text file 0000950170-24-124546.txt   21956217

Data Files

Seq Description Document Type Size
53 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20241112.xsd EX-101.SCH 23858
64 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20241112_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 241443225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)